Browse > Article

Influence of Rubiae Radix Extract on the Mechanism of Apoptosis in HL-60 Cells  

Choi, Ho-Seung (Department of Pathology, College of Oriental Medicine, Wonkwang University)
Park, Jin-Mo (Department of Pathology, College of Oriental Medicine, Wonkwang University)
Ju, Sung-Min (Department of Pathology, College of Oriental Medicine, Wonkwang University)
Kim, Sung-Hoon (Department of Oriental Pathology, College of Oriental Medicine, Kyunghee University)
Kim, Dae-Keun (College of Pharmacy, Woosuk University)
Kim, Won-Sin (Division of Natural Science, College of Natural Sciences, Wonkwang University)
Jeon, Byung-Hun (Department of Pathology, College of Oriental Medicine, Wonkwang University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.22, no.3, 2008 , pp. 548-555 More about this Journal
Abstract
Rubiae radix belonging to the family Rubiaceae have been used in traditional medicine to blood stasis and hemostasis. In this study, we reported that methanol extract of Rubiae radix (RRME) induced apoptotic cell death through MAPKs activation in human promylocytic leukemia (HL-60) cells. The cytotoxic activity of activity of RRME in HL-60 cells was increased in a dose-dependent manner. RRME was cytotoxic to HL-60 cells, with IC50 of $8{\mu}g/mL$. Treatment of RRME to HL-60 cells showed apoptotic bodies, and the fragmentation of DNA, suggesting that these cells underwent apoptosis. Caspase-3 activity and PARP cleavage were time-dependently increased the expression of Bcl-2 and Bax. And ratio of Bax/Bcl-2 protein expression. Activation of p38 and JNK were increased 6 hr after RRME treatment in HL-60 cells, but activation of ERK was reduced 24 hr after treatment. Taken together, these results suggest that RRME induces apoptotic cell death through activation of p38 and JNK in HL-60 cells.
Keywords
Rubiae radix; HL-60 cells; Apoptosis; Bax/Bcl-2 ratio; ERK; JNK; p38;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kalechman, Y., Longo, D.L., Catane, R., Shani, A., Albeck, M. and Sredni, B. Synergistic anti-tumoral effect of paclitaxel (Taxol)+AS101 in a murine model of B16 melanoma: association with ras-dependent signal-transduction pathways. Int. J. Cancer 86: 281-288, 2000   DOI   ScienceOn
2 Piazza, G.A., Rahm, A.L., Krutzsch, M., Sperl, G., Paranka, N.S., Gross, P.H., Brendel, K., Burt, R.W., Alberts, D.S., Pamukcu, R. and et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55: 3110-3116, 1995
3 Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng, T.I., Joens, D.P. and Wang, X. Prevention of apoptosis by Bcl-2: release of cytochrome C form mitochondria blocked. Science 275: 1129-1132, 1997   DOI
4 Luo, X., Budihardjo, I., Zou, H., Slaugheter, C. and Wang, X. Bcl-2 interaction protein, mediates cytochrome C release from mitochondria in response to activation of cell surface death receptor. Cell 94: 481-490, 1998   DOI   ScienceOn
5 李尙仁. 本草學. 醫藥社, pp 451-452, 1975
6 이재희. 圖說韓方 藥理藥能의 臨床應用. 學林社, p 544, 1985
7 陸昌洙. 現代本草學, 高文社, p 362, 1972
8 Hsu, Y.T. and Youle, R.J. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem. 273: 10777-10783, 1998   DOI   ScienceOn
9 Chan-Hui, P.Y. and Weaver, R. Human mitogen-activated protein kinase kinase kinase mediates the stress-induced activation of mitogen-activated protein kinase cascades. Biochem. J. 15: 599-609, 1998
10 Cobb, M.H. Goldsmith EJ. How MAP kinases are regulated. J. Biol. Chem. 270: 14843-14846, 1995   DOI   ScienceOn
11 田代華 主編. 實用中藥辭典. 人民衛生出版社, p 1259, 2002
12 Debatin, K.M., Poncet, D. and Kroemer, G. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene, 21: 8796-8803, 2002
13 辛佶求. 申氏本草學<各論>. 壽文社, pp 556-557, 1979
14 Gamet-Payrastre, L., Li, P., Lumeau, S., Cassar, G., Dupont, M.A., Chevolleau, S., Gasc, N., Tulliez, J. and Terce, F. Sulforaphane a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 60: 1426-1433, 2000
15 Evan, G. and Littlewood, T.A. matter of life and cell death. Science 281: 1317-1322, 1998   DOI
16 Thornberry, N.A. and Lazebnik, Y. Caspases: enemies within. Science 281: 1312-1316, 1998   DOI
17 Cross, T.G., Scheel-Toellner, D., Henriquez, N.V., Deacon, E., Salmon, M. and Lord, J.M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256: 34-41, 2000   DOI   ScienceOn
18 季宇杉 主編. 抗癌中藥藥理與應用. 黑龍江科學記述出版社, p 883, 1999
19 Li, P., Nijhawan, D., Budihardjo, O. and et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91: 479-489, 1997   DOI   ScienceOn
20 Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.E., Karandikar, M., Berman, K. and Cobb, M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22: 153-183, 2001   DOI   ScienceOn
21 辛民敎. 原色本草維新, 慶苑文化社, pp 168-169, 1979
22 Davis, R.J. Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252, 2000   DOI   ScienceOn
23 國家中醫藥管理局. 中華本草, 上海科學技術出版社, p 1542, 1998
24 Chang, L. and Karin, M. Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001   DOI   ScienceOn
25 Perlman, H., Zhang, X., Chen, M.W., Walsh, K. and Buttyan, R. An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death. Differ. 6: 48-54, 1999   DOI   ScienceOn
26 신민교. 原色臨床本草學. 發行所 南山堂, pp 435-436, 1986
27 Finucane, D.M., Bossy-Wetzel, E., Waterhouse, N.J., Cotter, T.G., Green, D.R. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem. 274: 2225-2233, 1993   DOI   ScienceOn
28 Finucance, D.M., Bossy-Wetzed, E., Waterhouse, N.J., Cotter, T.G. and Green D.R. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem. 274: 2225-2233, 1999   DOI   ScienceOn
29 Piao, W., Yoo, J., Lee, D.K., Hwang, H.J. and Kim, J.H. Induction of G(2)/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells. Biochem. Pharmacol. 62: 1439-1447, 2001   DOI   ScienceOn
30 이상인, 안덕균, 신민교, 노승현, 이영종, 김선희. 漢藥臨床應用, 成輔社, pp 255-256, 1986
31 Hui, H., Dotta, F., Di Mario, U. and Perfetti, R. Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death. J. Cell Physiol. 200: 177-200, 2004   DOI   ScienceOn
32 Cobb, M.H. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71: 479-500, 1999   DOI   ScienceOn
33 Tsiftsoglou, A.S., Pappas, I.S. and Vizirianakis, I.S. Mechanisms involved in the induced differentiation of leukemia cells. Pharmacol. Ther. 100: 257-290, 2003   DOI   ScienceOn
34 Okuno, T., Matsuoka, M., Sumizawa, T., Igisu, H. Involvement of the extracellular signal-regulated protien kinase pathway in phosphorylation of p53 protein and exerting cytotoxicity in human neuroblastoma cells (SH-SY5Y) exposed to acrylamide. Arch. Toxicol 80: 146-153, 2006   DOI   ScienceOn
35 Kim, R., Tanabe, K., Uchida, Y., Emi, M., Inoue, H. and Toge, T. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer, Chemother. Pharmacol. 50: 343-352, 2002   DOI   ScienceOn
36 王浴生 主編. 中藥藥理與應用. 人民衛生出版社, p 751, 1983
37 Murphy, K.M., Streips, U.N. and Lock, R.B. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2. Oncogene 18: 5991-5999, 1999   DOI   ScienceOn
38 Green, D.R. and Reed, J.C. Mitochondria and apoptosis. Science 281: 1309-1312, 2003   DOI
39 Nieves-Neira, W. and Pommier, Y. Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI Anticancer Drug Screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways. Int. J. Cancer 82: 396-404, 1999   DOI   ScienceOn
40 Kim, R., Tanabe, K., Uchida, Y., Emi, M., Inoue, H. and Toge, T. Current satus of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancenr chemotherapy. Cancer Chemother. Pharmacol. 50: 343-352, 2002   DOI   ScienceOn
41 Kluck, R.M., Bossy-Wetzel, E., Green, D.R. and Newmeyer, D.D. The release of cytochrome C from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 22: 155-156, 1997
42 신민교, 이상인 외 14인. 本草學. 圖書出版 永林社, pp 402-403, 1999
43 李時珍. 本草綱目, 中國中醫藥出版社, p 564, 1998
44 Ling, Y.H., Yang, Y., Tornos, C., Singh, B. and Perez-Soler, R. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells. Cancer Res. 58: 3633-3640, 1998
45 Johnson, B.W., Cepero, E. and Boise, L.H. Bcl-xL inhibits cytochrome c release but not mitochondrial depolarization during the activation of multiple death pathways by tumor necrosis factor-alpha. J. Biol. Chem. 275: 31546-31553, 2000   DOI   ScienceOn
46 Ruffolo, S.C., Breckenridge, D.G., Nguyen, M., Goping, I.S., Gross, A., Korsmeyer, S.J., L, H., Yuan, J., Shore, G.C. BID-dependent and BID-independent pathways for BAX insertion into mitochondria. Cell Death Differ. 7: 1101-1108, 2000   DOI   ScienceOn
47 Johnson, G.L. and Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912, 2002   DOI   ScienceOn
48 鄭虎古 等 主編. 中藥現代硏究與應用(第四卷). 北京學苑出版社, p 3066, 1998
49 Ichijo, H. Differentiation of the chick retinotectal topographic map by remodeling in specificity and refinement in accuracy. Brain Res. Dev. Brain Res. 117: 199-211, 1999   DOI   ScienceOn
50 Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. and Greenberg, M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995   DOI
51 Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J.. and Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995   DOI